About Priyanka Mandal

Priyanka is a passionate investment analyst and commentator. After earning a master's degree in economics, her interest in financial markets motivated her to begin her career in investment research. Her approach is to find a financial instruments’ intrinsic value for predicting its future price movement.


Recent Articles By Priyanka Mandal

: CZOO |  News, Ratings, and Charts

3 Under the Radar Stocks Wall Street Loves

Rising inflationary pressure, a weak job market, and the Fed’s potential tapering could prolong stock market instability in the near term. However, the market is expected to generate some momentum later this month as the earnings season kicks off. As such, Wall Street analysts expect lesser-known stocks Cazoo Group (CZOO), 23andMe (ME), and Sharecare (SHCR) to deliver decent upside. Read on.
: BABA |  News, Ratings, and Charts

3 Meme Stocks Wall Street Predicts Will Rally by 40% or More

While the hype surrounding popular short-squeeze candidates is fading, some new names have been hogging the spotlight of late. Wall Street analysts expect Alibaba Group (BABA), Tilray (TLRY), and ContextLogic (WISH) to gain 40% or more in price in the coming months because they are among the most-mentioned stocks on subreddit WallStreetBets. So, let’s discuss.
: USNA |  News, Ratings, and Charts

3 Undervalued Consumer Defensive Stocks in Utah to Scoop Up This Month

Worries surrounding a disappointing employment report and tight supply chain could fuel stock market volatility this month. In such an environment, we believe that betting on consumer defensive stocks, which usually exhibit defensive qualities due to the relatively inelastic demand for their products, could be a good strategy to hedge one’s portfolio. Given the continued increase in consumer spending and market volatility, we think undervalued consumer defensive stocks USANA Health Sciences (USNA), Nature's Sunshine (NATR), and LifeVantage (LFVN) could be ideal picks now. So, let’s examine these names.
: GVA |  News, Ratings, and Charts

2 Industrial Stocks with Great Growth Prospects

As the resumption in economic activities and construction works boosts industrial production, the sector is gradually recovering from its pandemic-induced downturn. This, along with the government’s infrastructure spending plans, bode well for fundamentally strong industrial stocks Granite Construction (GVA) and Heritage-Crystal (HCCI). They possess solid growth potential, and we think are poised to see their shares soar in price in the near term. Read on.
: WBA |  News, Ratings, and Charts

3 Dividend Aristocrats to Buy on the Dip

Although the major benchmark indices are showing some resilience lately, October could be a volatile month given concerns related to supply chain constraints and potential monetary policy changes. Given the uncertain market conditions, we believe the recent price dips in dividend aristocrats Walgreens Boots (WBA), West Pharmaceutical (WST), and W.W. Grainger (GWW) offer solid entry opportunities.
: STNE |  News, Ratings, and Charts

3 Software Stocks Wall Street Predicts Will Gain More Than 75%

As the pandemic has accelerated digital transformation, businesses are increasingly adopting software services. Moreover, the remote working culture has increased dependence on software significantly. Since the software market is expected to keep growing, Wall Street analysts expect prominent players in this space, StoneCo (STNE), Zedge (ZDGE), and Verb Technology (VERB), to witness significant upside in the coming months.
: BYND |  News, Ratings, and Charts

4 Meme Stocks to Avoid Like the Plague in October

Meme stocks gained immense popularity earlier this year following the GameStop (GME) short squeeze due to social media hype. While the dizzying rallies caught the attention of retail traders, most meme stocks are risky as their fundamental strength does not back up these massive gains. We believe fundamentally weak meme stocks Beyond Meat (BYND), SmileDirectClub (SDC), Rocket Lab (RKLB), and Ocugen (OCGN) could see a significant pullback in the near term. So, investors should avoid these stocks for now.
: CLDR |  News, Ratings, and Charts

1 Data Analytics Stocks to Buy, 1 to Avoid

Rising adoption of predictive analysis methods in almost every sector using advanced techniques reliant on big data has contributed significantly to the growth of the data analytics industry. So, a fundamentally strong stock in this space, Cloudera (CLDR), is worth betting on now. Conversely, Cardlytix (CDLX) doesn’t look well-positioned to capitalize on the industry tailwinds due to its poor fundamentals. So it is best avoided now.
: SNN |  News, Ratings, and Charts

3 Stocks That Could Bounce Back in the Fourth Quarter

Despite concerns surrounding the Fed tapering asset purchases, many analysts expect stocks to continue making new highs after a turbulent period in September. Thus, fundamentally sound stocks Smith & Nephew (SNN), DaVita (DVA), and Orthofix Medical (OFIX) could witness a rebound in the near term.
: TBI |  News, Ratings, and Charts

2 Supercharged Staffing Stocks to Buy Right Now

While stagnant hiring due to forced shutdowns and business closures affected the staffing industry last year, it is gradually reviving thanks to record-high job openings and an increase in contract staffing job rates. Consequently, we think quality staffing stocks such as TrueBlue (TBI) and Resources Connection (RGP) could soar in the coming months.
Page generated in 1.2559 seconds.